• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Validated RP-HPLC Method Measures Doxorubicin and 5F in Mouse Plasma

by
November 10, 2026
in Chemistry
Reading Time: 2 mins read
0
Validated RP-HPLC Method Measures Doxorubicin and 5F in Mouse Plasma

Validated RP-HPLC Method Measures Doxorubicin and 5F in Mouse Plasma

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A reversed-phase high-performance liquid chromatography assay has been developed and validated to simultaneously measure two antitumor compounds, doxorubicin and ent-11α-hydroxy-15-oxo-kaur-16-en-19-oic-acid, in KM mouse plasma following intravenous administration. The analytical method was established to support pharmacokinetic investigations of both therapeutic agents when delivered together in nanoliposome formulations.

To evaluate the co-delivery system, researchers prepared nanoliposomes co-loaded with doxorubicin and 5F using a thin-film hydration method. The dual-agent nanoliposomes were then administered intravenously to KM mice to provide biological samples for subsequent chromatographic testing and pharmacokinetic evaluation.

Isolating the two active compounds from the biological matrix required sample preparation prior to instrument analysis. The team utilized liquid-liquid extraction with methanol as the extraction solvent to separate doxorubicin and 5F from the collected mouse plasma specimens.

Chromatographic separation was conducted on an Agilent 1260 series liquid chromatography system fitted with a Hypersil ODS C18 column. The mobile phase consisted of a 40:60 volume-to-volume mixture of methanol and 1% glacial acetic acid delivered at a flow rate of 1.0 mL min−1. Column temperature was maintained at 30 °C ± 2 °C, ultraviolet detection was performed at a wavelength of 242 nm, and naproxen served as the internal standard.

Specificity and matrix effects were evaluated in both pharmaceutical and biological environments in accordance with International Council for Harmonisation guidelines. Blank liposome formulations spiked with doxorubicin and 5F were disrupted using methanol and analyzed by liquid chromatography. In parallel, matrix effects in plasma were evaluated across six individual blank plasma lots spiked post-extraction at three quality control concentrations of 0.125, 0.25, and 0.5 μg mL−1 for both compounds, revealing no significant interference with separation or detection under the established conditions.

The validated assay demonstrated linear concentration ranges of 0.125 to 2.0 μg mL−1 for doxorubicin and 0.0625 to 0.6 μg mL−1 for 5F, with both analytes yielding correlation coefficients exceeding 0.998. Extraction recoveries from quality control samples spanned 84.2% to 85.5% for doxorubicin and 86.2% to 87.1% for 5F, while intra-day and inter-day precisions remained below 10% across all evaluated control concentrations. The limits of quantitation were established at 60 ng mL−1 for doxorubicin and 20 ng mL−1 for 5F.

The authors concluded that the analytical protocol achieved satisfactory precision, accuracy, and acceptable limits of quantitation for biological monitoring. Under the reported experimental parameters, the validated reversed-phase assay provides an analytical foundation suitable for evaluating the pharmacokinetic profiles of doxorubicin and 5F in mice.

Subject of Research: Simultaneous RP-HPLC determination of doxorubicin and 5F in mouse plasma

Article Title: Validated RP-HPLC method for simultaneous determination of doxorubicin and 5F: application in nanoliposome formulation development and pharmacokinetic studies

Article References: Duan, Z., Zheng, C., Yu, Z., Fu, H., Zhou, Y., & Huang, Y. (2026). Validated RP-HPLC method for simultaneous determination of doxorubicin and 5F: application in nanoliposome formulation development and pharmacokinetic studies. Frontiers in Chemistry, 14, Article 2005154. https://doi.org/10.3389/fchem.2026.2005154

Image Credits: AI Generated

DOI: 10.3389/fchem.2026.2005154

Keywords: RP-HPLC, doxorubicin, 5F, pharmacokinetics, nanoliposomes, liquid-liquid extraction, KM mice, Validated, method, simultaneous, determination, application

News Source: Bethany Barker. (November 10, 2026). Validated RP-HPLC Method Measures Doxorubicin and 5F in Mouse Plasma. Scienmag.

Tags: 5FapplicationdeterminationdoxorubicinKM miceliquid-liquid extractionmethodnanoliposomesPharmacokineticsRP-HPLCsimultaneousvalidated
Share12Tweet7Share2ShareShareShare1

Related Posts

Copper Oxide Composite Breaks Down Antibiotic Pollutant Under Natural Sunlight

Copper Oxide Composite Breaks Down Antibiotic Pollutant Under Natural Sunlight

November 17, 2026
Fluorine Substitution Retards Thallium Oxidation of Benzoic Acid Hydrazides in Acid

Fluorine Substitution Retards Thallium Oxidation of Benzoic Acid Hydrazides in Acid

November 17, 2026

Gellan Gum and Hydrocolloids Control Anthocyanin Dissolution in Vegan Jelly Candies

November 17, 2026

Chemists Synthesize a Singlet Palladium-Gold Dimetallocarbene With Ambiphilic Reactivity

November 17, 2026

POPULAR NEWS

  • De Novo Unbalanced X;14 Translocation Linked to Turner Syndrome Phenotype

    De Novo Unbalanced X;14 Translocation Linked to Turner Syndrome Phenotype

    29 shares
    Share 12 Tweet 7
  • Nepal Survey Finds Stable Drug-Resistant Tuberculosis Rates Alongside Rising Fluoroquinolone Resistance

    29 shares
    Share 12 Tweet 7
  • Systematic Review Finds No Clear Mortality Benefit Across Six Sepsis Treatments

    29 shares
    Share 12 Tweet 7
  • Surgical Internet of Medical Things Faces Cyber Threats Endangering Patient Safety

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Study Identifies Four Motivations for Women Terminating Unwanted Pregnancies

3D Facial Scan Integration of Dental Models Shows Low Clinical Error

Exome and Copy Number Analysis Diagnose 31.7 Percent of Pediatric Immune Cases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.